Search research articles
Contact Us
Filters
Showing results (621-630 of 706) with videos related to
Page
of 71
Sort By:
Neuro-Oncology
|
April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
The New England Journal of Medicine
|
September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations
Eric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Pediatric Neurosurgery
|
January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study
M Deutsch, P R Thomas, J Krischer, et al.
Cancer
|
October 10, 2013
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022)
Jason Fangusaro, Sridharan Gururangan, Tina Young Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study
P M Zeltzer, J M Boyett, J L Finlay, et al.
Neuro-Oncology
|
December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology
|
February 15, 2020
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference
Roger J Packer, Antonio Iavarone, David T W Jones, et al.
Journal of Medicinal Chemistry
|
May 21, 2024
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Peter Barton, Erin Braybrooke, et al.
Developmental Cell
|
August 24, 2021
Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors
Emmanuelle S Jecrois, Wang Zheng, Miriam Bornhorst, et al.
Neuro-Oncology
|
April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee
Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Page
of 71
Search research articles
Search
Showing results (621-630 of 706) with videos related to
Sort By:
Page
of 71
Neuro-Oncology
|
April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
The New England Journal of Medicine
|
September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations
Eric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Pediatric Neurosurgery
|
January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study
M Deutsch, P R Thomas, J Krischer, et al.
Cancer
|
October 10, 2013
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022)
Jason Fangusaro, Sridharan Gururangan, Tina Young Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study
P M Zeltzer, J M Boyett, J L Finlay, et al.
Neuro-Oncology
|
December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology
|
February 15, 2020
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference
Roger J Packer, Antonio Iavarone, David T W Jones, et al.
Journal of Medicinal Chemistry
|
May 21, 2024
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Peter Barton, Erin Braybrooke, et al.
Developmental Cell
|
August 24, 2021
Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors
Emmanuelle S Jecrois, Wang Zheng, Miriam Bornhorst, et al.
Neuro-Oncology
|
April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee
Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Page
of 71